Last reviewed · How we verify

NCT04457167: RMR

Mastectomy With Retention of the Nipple-areola Complex, Robot-assisted or Not, and / or Immediate or Seconday Reconstruction by Latissimus Dorsi Flap, Robot-assisted or Not.

Not yet recruiting NA Last updated 7 July 2020
What this trial tests

NA trial testing Robot-assisted in Mastectomy in 480 participants. Not yet recruiting.

Timeline
1 November 2020
Primary endpoint
1 November 2023
1 November 2026

Quick facts

Lead sponsorInstitut Paoli-Calmettes
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment480
Start date1 November 2020
Primary completion1 November 2023
Estimated completion1 November 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Institut Paoli-Calmettes — full company profile →

Who can join

18 and older, female only, with Mastectomy or Breast Reconstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Phase III, non-randomized, monocentric, observational, prospective trial. It is planned to recruit a total of 480 patients, including 240 patients receiving mastectomy with preservation of the nipple-areola complex and 240 patients with a reconstruction with latissimus dorsi flap, or in immediate reconstruction, or during secondary reconstruction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Mastectomy with Reconstruction Including Robotic Endoscopic Surgery (MARRES): a prospective cohort study of the Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) and Korean Breast Cancer Study Group (KBCSG).
    Ryu JM, Lee J, Lee J, Ko B, et al · · 2023 · cited 19× · PMID 37344780 · DOI 10.1186/s12885-023-10978-0

Verify or expand the search:

Other trials of Robot-assisted

Trials testing the same drug.

Other recruiting trials for Mastectomy

Currently open trials in the same condition.

Other Institut Paoli-Calmettes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04457167.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing